Intravitreal injections during COVID-19 outbreak: Protective measures, total duration of care and perceived quality of care in a tertiary retina center
- PMID: 33752454
- PMCID: PMC7992096
- DOI: 10.1177/11206721211003488
Intravitreal injections during COVID-19 outbreak: Protective measures, total duration of care and perceived quality of care in a tertiary retina center
Abstract
Purpose: To assess patient satisfaction regarding the sudden reorganization of care during the COVID-19 pandemic in the outpatient intravitreal injection (IVI) clinic.
Methods: A survey of patients with ongoing IVIs for retinal diseases was carried out between April 23rd and May 12th, 2020. We designed a questionnaire to assess patient satisfaction concerning: personal protective equipment (PPE), social distancing, the perceived quality of care, and the total time spent in the department, using a Likert scale. We also collected the time spent per patients in the outpatient IVI clinic.
Results: A hundred and twenty-seven eyes of 108 patients were included. The mean time spent in the IVI outpatient clinic was 31.87 +/- 16.61 min. In our survey, 99.1% of the patients were satisfied (highly satisfied or satisfied) with the new type of care provided, 89.8% with the duration of care, and 93.5% with the PPE. Satisfaction was associated with total time spent in hospital (p = 0.005), with dissatisfied patients spending about 50% more time in the hospital than satisfied patients (43.91 min vs 30.50 min).
Conclusion: Despite the crisis-related adjustment, our survey revealed high patient satisfaction with PPE, quality of care, and total time spent in outpatient IVI clinic.
Keywords: COVID-19; Intravitreal injections; age-related macular degeneration; diabetic macular edema; patient satisfaction; treatment burden.
Conflict of interest statement
Similar articles
-
Assessment of Patients' Confidence Regarding a New Triage Concept in a Medical Retina Clinic during the First COVID-19 Outbreak.Int J Environ Res Public Health. 2021 May 29;18(11):5846. doi: 10.3390/ijerph18115846. Int J Environ Res Public Health. 2021. PMID: 34072435 Free PMC article.
-
Impact of the COVID-19 pandemic's first wave on the care and treatment situation of intravitreal injections in a German metropolitan region.Graefes Arch Clin Exp Ophthalmol. 2022 Jun;260(6):1877-1886. doi: 10.1007/s00417-021-05521-5. Epub 2022 Jan 10. Graefes Arch Clin Exp Ophthalmol. 2022. PMID: 35006330 Free PMC article.
-
Hybrid Telehealth Medical Retina Clinic Due to Provider Exposure and Quarantine During COVID-19 Pandemic.Clin Ophthalmol. 2020 Oct 21;14:3421-3426. doi: 10.2147/OPTH.S276276. eCollection 2020. Clin Ophthalmol. 2020. PMID: 33116394 Free PMC article.
-
Modifications of intravitreal injections in response to the COVID-19 pandemic.J Chin Med Assoc. 2021 Sep 1;84(9):827-832. doi: 10.1097/JCMA.0000000000000588. J Chin Med Assoc. 2021. PMID: 34292208 Review.
-
Anti-VEGF intravitreal injections in the era of COVID-19: responding to different levels of epidemic pressure.Graefes Arch Clin Exp Ophthalmol. 2021 Mar;259(3):567-574. doi: 10.1007/s00417-021-05097-0. Epub 2021 Feb 2. Graefes Arch Clin Exp Ophthalmol. 2021. PMID: 33528647 Free PMC article. Review.
Cited by
-
Reported Rates of Intraocular Inflammation with Intravitreal Aflibercept Administered via Pre-Filled Syringe or from Vials in Clinical Practice Between 2012 and 2022.Clin Ophthalmol. 2023 Jan 26;17:385-390. doi: 10.2147/OPTH.S393519. eCollection 2023. Clin Ophthalmol. 2023. PMID: 36726365 Free PMC article.
-
Therapeutic effect of simultaneous intravitreal dexamethasone and aflibercept on diabetic macular edema.Acta Diabetol. 2022 Apr;59(4):501-508. doi: 10.1007/s00592-021-01824-5. Epub 2021 Nov 16. Acta Diabetol. 2022. PMID: 34786634 Free PMC article.
References
-
- World Health Organization. Coronavirus disease 2019 (COVID-19): situation report. World Health Organization, https://apps.who.int/iris/handle/10665/331450 (accessed on 15 May 2020).
-
- American Macular Degeneration Foundation. Coronavirus and your macular degeneration care, https://www.macular.org/2020/03/19/coronavirus-and-your-macular-degenera... (accessed on 15 May 2020).
-
- Société française d’ophtalmologie (2020). Covid-19: recommandations aux ophtalmologistes, https://www.sfo-online.fr/covid-19-infos (accessed on 15 May 2020).
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous